In vivo RNAi screening for novel therapeutic cancer targets

被引：0
|
作者：
Peeper, D. [1 ]
机构：
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Oncol, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50025-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] Comprehensive genomics-based screening of novel therapeutic targets and biomarkers for lung cancer.
    Daigo, Yataro
    Takano, Atsushi
    Nakamura, Yusuke
    CANCER RESEARCH, 2022, 82 (12)
  • [42] Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
    Azorsa, David O.
    Gonzales, Irma M.
    Basu, Gargi D.
    Choudhary, Ashish
    Arora, Shilpi
    Bisanz, Kristen M.
    Kiefer, Jeffrey A.
    Henderson, Meredith C.
    Trent, Jeffrey M.
    Von Hoff, Daniel D.
    Mousses, Spyro
    JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [43] Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer
    David O Azorsa
    Irma M Gonzales
    Gargi D Basu
    Ashish Choudhary
    Shilpi Arora
    Kristen M Bisanz
    Jeffrey A Kiefer
    Meredith C Henderson
    Jeffrey M Trent
    Daniel D Von Hoff
    Spyro Mousses
    Journal of Translational Medicine, 7
  • [44] RNAi screen identifies therapeutic targets in hepatocellular carcinoma
    Huang, Chun-Hao
    Lujambio, Amaia
    Zuber, Johannes
    Kitzing, Thomas
    Tschaharganeh, Darjus F.
    Stanchina, Elisa D.
    Lowe, Scott W.
    CANCER RESEARCH, 2014, 74 (19)
  • [45] CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
    Noorani, Imran
    Bradley, Allan
    de la Rosa, Jorge
    GENOME BIOLOGY, 2020, 21 (01)
  • [46] CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
    Imran Noorani
    Allan Bradley
    Jorge de la Rosa
    Genome Biology, 21
  • [47] Discovery and in vivo validation of novel cancer targets of orphan receptor and protein kinase using inducible RNAi xenograft models.
    Ke, N
    Zhou, DM
    Fan, WF
    Chatterton, JE
    Sundaram, R
    Chionis, J
    Zhang, J
    Hu, XY
    Yu, DH
    Awald, T
    Meyhack, B
    Brachat, A
    Paoni, NF
    Wong-Staal, F
    Li, HQX
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9164S - 9164S
  • [48] Identification of MLL4 as a novel therapeutic target of pancreatic ductal adenocarcinoma by in vivo genome-wide RNAi screening.
    Fung, Frederic K. C.
    Zhu, Yinxin
    Wong, Chi Hin
    Chen, Yangchao
    CANCER RESEARCH, 2020, 80 (22)
  • [49] Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis
    Konstantin Stoletov
    Lian Willetts
    Robert J. Paproski
    David J. Bond
    Srijan Raha
    Juan Jovel
    Benjamin Adam
    Amy E. Robertson
    Francis Wong
    Emma Woolner
    Deborah L. Sosnowski
    Tarek A. Bismar
    Gane Ka-Shu Wong
    Andries Zijlstra
    John D. Lewis
    Nature Communications, 9
  • [50] Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis
    Stoletov, Konstantin
    Willetts, Lian
    Paproski, Robert J.
    Bond, David J.
    Raha, Srijan
    Jovel, Juan
    Adam, Benjamin
    Robertson, Amy E.
    Wong, Francis
    Woolner, Emma
    Sosnowski, Deborah L.
    Bismar, Tarek A.
    Wong, Gane Ka-Shu
    Zijlstra, Andries
    Lewis, John D.
    NATURE COMMUNICATIONS, 2018, 9
12345